Is Pharmakogenetik Medicheck useful for allergy?

The Pharmakogenetik Medicheck from MyBody-X analyzes genetic variants affecting drug metabolism. For allergies, its clinical utility is limited. While genes like HNMT (histamine metabolism) or CYP450 enzymes influence antihistamine processing, evidence for personalized allergy treatment based on these markers is weak. Current guidelines do not recommend routine pharmacogenetic testing for allergies. The test may offer insights but cannot replace clinical evaluation or therapy adjustment. Most associations stem from GWAS or mechanistic studies without robust clinical validation. Allergies are multifactorial—environment, immune status, and exposure are more decisive than single gene variants. Thus, the test is best seen as supplementary information, not a diagnostic or dosing tool. Caveat: No consumer DNA test can diagnose allergies or safely guide medication use.